INCANNEX HEALTHCARE LIMITED (ASX:IHL) - Ann: IHL-42X positive phase 2 clinical trial results, 61300329, page-387 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum

Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

Click for more information

0.00%

4.1¢ incannex healthcare limited

First 387 Last

Share
Profile

Follow
Paulfool

1,273 Posts.

739

09/05/22

22:08

Post #: 61300329
Share

Originally posted by Paulfool: ↑

For Standard Drug development this is the process, and it is a very long and perilous journey but if successful the pay off is substantial.

Key points that make Incannex very interesting and quite unique are that the Board has chosen to pursue target total addressable markets in excess of $1billion per year which helps the risk/reward ratio. On the General Thread there is a rough future Share Price calculatation for Incannex vs Cochlear based on hypothetical sales of IHL-42X for OSA.

Each of the targeted areas are unmet or under served by current pharmacological treatments and are using existing pharmaceutical approved drugs but just in combination which is of much more significance as the design of each separate trial is to pursue the expedited 505 2 B FDA approval process.

In addition to this Incannex are utilise Camargo (Now called Premier Consulting) to facilitate all discussions with the FDA. In last year's PING Pre IND meeting IHL675A was confirmed to qualify for this and fingers crossed the meeting on 11th May will confirm the same for IHL-42X.
This will shave years off standard development timeframes.

It is no accident that IHL-42X contains Dronabinol and IHL-675A used Epidiolex.

Expand

IHL Price at posting: 38.0¢ Sentiment: Buy Disclosure: Held
16 Upvote

0 Great analysis

Reply

Top Stories

MCT

Metalicity looking for offers on Admiral Bay zinc project

FG1

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

GNX

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

LKE

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

AI stocks: What to expect in 2024-25

Talking Australia's very competitive property landscape: Realty Talks

IMR

Imricor raises $35M to pursue growth and expansion into Australia and NZ

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

There are more pages in this discussion • 3 more messages in this thread...

First 387 Last

Add IHL (ASX) to my watchlist